Suchergebnisse - "Wilms tumor"

PubPharm (2.215)

1

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor : Treatment for Patients With Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor

enthalten in: ClinicalTrials.gov | 2024

2

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

enthalten in: ClinicalTrials.gov | 2024

3

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Ensartinib in Patients With Tumors Harboring ALK or ROS1 Genomic Alterations

enthalten in: ClinicalTrials.gov | 2024

4

A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor

enthalten in: BMC pediatrics | 2024

von Guo, Y. | Lu, W. | Zhang, Z. | +8

5

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- A Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes

enthalten in: ClinicalTrials.gov | 2024

6

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients With Tumors Harboring Activating Alterations in Cell Cycle Genes

enthalten in: ClinicalTrials.gov | 2024

7

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor : Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor

enthalten in: ClinicalTrials.gov | 2024

8

Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor : A retrospective analysis

enthalten in: Urologic oncology | 2024

von Wang, Z. | Li, J. | Liu, P. | +3

9

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults : Phase I Study of B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

enthalten in: ClinicalTrials.gov | 2024

10

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT : Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[222]